Lataa...
Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies
BACKGROUND: Ovarian cancer is the third leading cause of death among gynecological cancers in women in China. Chemotherapy is an important method for comprehensive treatment of ovarian cancer, but the curative effect is poor. PURPOSE: In this study, gemcitabine (GEM) -loaded RGD modified liposomes (...
Tallennettuna:
| Julkaisussa: | Drug Des Devel Ther |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6756163/ https://ncbi.nlm.nih.gov/pubmed/31571830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S211168 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|